ArticlePathology oncology research : POR2019

Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis.

Alessandro Inno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.